1. Market Research
  2. > Pathology Industry

lymphoma Industry, April 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, In Vitro Instrument, Flow Cytometry, Pap Smear, Oncology, Therapeutics, Antibody, Clinical Trial, Computed Tomography, Pharmaceutical, Blood Supply, Cancer Diagnostic, Nuclear Imaging, Nuclear Medicine, Rituximab, Therapy.


 
1-10 of about 100 reports for Lymphoma

Purchase Reports From Reputable Market Research Publishers

Global Non-Hodgkin Lymphoma Partnering 2010 to 2016

Global Non-Hodgkin Lymphoma Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • April 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. - Trends ...

Global Lymphoma Partnering 2010 to 2016

Global Lymphoma Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • April 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. - Trends ...

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • March 2016
  • by Global Markets Direct

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016’, provides an overview of the Peripheral ...

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2016
  • by Global Data

Summary The Leukemia & Lymphoma Society, Inc. (LLS) is a healthcare company that offers blood cancer researches and funds raising services. The company’s services include patient services, health education, ...

Indolent Lymphoma - Pipeline Review, H1 2016

Indolent Lymphoma - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • February 2016
  • by Global Markets Direct

Indolent Lymphoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Indolent Lymphoma pipeline landscape. The ...

Mantle Cell Lymphoma - Pipeline Review, H1 2016

Mantle Cell Lymphoma - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • February 2016
  • by Global Markets Direct

Mantle Cell Lymphoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape. ...

Hodgkin Lymphoma - Pipeline Review, H1 2016

Hodgkin Lymphoma - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • February 2016
  • by Global Markets Direct

Hodgkin Lymphoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Hodgkin Lymphoma pipeline landscape. The report ...

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • February 2016
  • by Global Markets Direct

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016’, provides an overview of the Anaplastic ...

Lymphoma Drug Pathway Analyzer

Lymphoma Drug Pathway Analyzer

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 516 targeted molecular therapies known to affect more than 244 specific intracellular signaling pathways ...

Lymphoma Drug Pipeline Update

Lymphoma Drug Pipeline Update

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. There are today 369 companies plus partners developing 521 lymphoma drugs in 949 developmental projects in cancer. In ...

About 2 800 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Canada

  • October 2015
    201 pages
  • Cancer  

    Rituximab  

    Cancer Drug  

  • Canada  

View report >

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.